We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$112B
AUM Growth
+$9.17B
Cap. Flow
+$3.28B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.06%
Holding
4,415
New
305
Increased
1,505
Reduced
1,905
Closed
456

Sector Composition

Rank Sector Weight
1 Technology 11.36%
2 Financials 11.09%
3 Healthcare 9.9%
4 Consumer Discretionary 6.79%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCSM icon
3651
NCS Multistage Holdings
NCSM
$117M
$163K ﹤0.01%
+556
New +$206K
LUMO
3652
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$163K ﹤0.01%
2,236
-3,756
-63% -$311K
ECOM
3653
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$163K ﹤0.01%
18,155
-9,405
-34% -$93K
SVA
3654
DELISTED
Sinovac Biotech, Ltd
SVA
$163K ﹤0.01%
20,700
-4,039
-16% -$30.2K
SE icon
3655
Sea Limited
SE
$66.3B
$162K ﹤0.01%
+12,135
New +$166K
OCUL icon
3656
Ocular Therapeutix
OCUL
$1.84B
$161K ﹤0.01%
36,300
-208,844
-85% -$1.07M
FGP
3657
DELISTED
Ferrellgas Partners, L.P.
FGP
$158K ﹤0.01%
36,971
-19,659
-35% -$90.6K
CTSO icon
3658
Cytosorbents Corp
CTSO
$23.3M
$157K ﹤0.01%
+24,148
New +$154K
MYN icon
3659
BlackRock MuniYield New York Quality Fund
MYN
$377M
$157K ﹤0.01%
12,200
NETI
3660
DELISTED
Eneti Inc.
NETI
$157K ﹤0.01%
2,282
-3,248
-59% -$226K
KDNY
3661
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$157K ﹤0.01%
4,196
-3,502
-45% -$153K
FMNB icon
3662
Farmers National Banc Corp
FMNB
$952M
$156K ﹤0.01%
10,564
-7,082
-40% -$105K
AVXL icon
3663
Anavex Life Sciences
AVXL
$232M
$153K ﹤0.01%
47,192
-14,824
-24% -$58.3K
EMKR
3664
DELISTED
Emcore Corp
EMKR
$153K ﹤0.01%
2,373
+18
+0.8% +$1.35K
OREX
3665
DELISTED
Orexigen Therapeutics, Inc.
OREX
$153K ﹤0.01%
118,770
-124,099
-51% -$202K
TYME
3666
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$152K ﹤0.01%
+23,820
New +$106K
VIIZ
3667
DELISTED
CREDIT SUISSE NASSAU BRH VS VIX MID TERM (BHS)
VIIZ
$152K ﹤0.01%
25,050
URA icon
3668
Global X Uranium ETF
URA
$5.19B
$151K ﹤0.01%
+10,000
New +$139K
RMTI icon
3669
Rockwell Medical
RMTI
$27.2M
$147K ﹤0.01%
231
-276
-54% -$194K
BRS
3670
DELISTED
Bristow Group, Inc.
BRS
$146K ﹤0.01%
10,841
-28,127
-72% -$333K
CUK
3671
DELISTED
Carnival PLC
CUK
$144K ﹤0.01%
+2,180
New +$145K
HLIT icon
3672
Harmonic Inc
HLIT
$1.14B
$144K ﹤0.01%
34,087
-67,510
-66% -$253K
GRBK icon
3673
Green Brick Partners
GRBK
$3.13B
$143K ﹤0.01%
12,624
-5,938
-32% -$65.2K
NGVC icon
3674
Vitamin Cottage Natural Grocers
NGVC
$757M
$142K ﹤0.01%
+15,961
New +$105K
CSLT
3675
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$141K ﹤0.01%
37,659
-25,028
-40% -$100K

Similar funds

Credit Suisse's Q4 2017 Portfolio in Review

As of Q4 2017, Credit Suisse held 4,415 positions worth $112B, up 8.9% from $103B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse's Q4 2017 filing shows 305 new, 1,505 increased, 1,905 reduced and 456 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M. The largest sale was iShares MSCI South Korea ETF, an estimated $280M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Credit Suisse's largest Q4 2017 buy was Vanguard FTSE Pacific ETF: 1,427,144 shares worth $104M.
  • Credit Suisse added most to Citigroup in Q4 2017, an estimated $424M increase.
  • Credit Suisse's biggest Q4 2017 reduction was iShares MSCI South Korea ETF, cutting an estimated $280M.
  • Credit Suisse fully exited Fortress Investment Group Llc in Q4 2017, selling an estimated $86.9M.
  • Credit Suisse's ten largest holdings make up 16% of its $112B portfolio in Q4 2017.
  • Credit Suisse opened 305 new positions and closed 456 in Q4 2017.
  • Credit Suisse's portfolio value rose 8.9% quarter-over-quarter to $112B.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.